Sirdás sisdollui
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Giella
Buot deaivamat
Bajilčálus
Dahkki
Fáddá
Hildobáiki
ISBN/ISSN
Fáddágilkor
Viečča
Aiddostahtton
Analysis of stored oligosaccha...
Čujuhandieđut
Deakstadieđáhus
Sádde šleađgaboasttain
Čálit
Doalvvo čujuhusa
Doalvun: RefWorks
Doalvun: EndNoteWeb
Doalvun: EndNote
Bissovaš liŋka
Analysis of stored oligosaccharides in a mouse model of a glycolipid storage (Sandhoff) disease
Bibliográfalaš dieđut
Váldodahkkit:
Awan, F
,
Lowe, J
,
Neville, D
,
Stucky, D
,
Blamire, A
,
Smith, D
,
Griffin, J
,
Jeyakumar, M
,
Styles, P
,
Sibson, N
,
Platt, F
Materiálatiipa:
Conference item
Almmustuhtton:
2003
Oažžasuvvandieđut
Govvádus
Geahča maid
Bargiidšearbma
Geahča maid
MRS reveals additional hexose N-acetyl resonances in the brain of a mouse model for Sandhoff disease.
Dahkki: Lowe, J, et al.
Almmustuhtton: (2005)
NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin.
Dahkki: Jeyakumar, M, et al.
Almmustuhtton: (2004)
Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease.
Dahkki: Andersson, U, et al.
Almmustuhtton: (2004)
Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice.
Dahkki: te Vruchte, D, et al.
Almmustuhtton: (2010)
Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease
Dahkki: Ulrika Andersson, et al.
Almmustuhtton: (2004-08-01)